MedPath

Exercise training effects on biochemical, metabolic, physical fitness, body composition and hemodynamic markers

Not Applicable
Completed
Conditions
Overweight
Obesity
Inflammatory and Immune System - Other inflammatory or immune system disorders
Diet and Nutrition - Obesity
Metabolic and Endocrine - Other metabolic disorders
Registration Number
ACTRN12615001000594
Lead Sponsor
Fundacao de Amparo a Pesquisa de Sao Paulo - FAPESP. Foundation of the Sao Paulo Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
80
Inclusion Criteria

. Inactive middle-aged male subjects with body mass index (BMI) between 25 and 34.9 kg/m^2 were recruited through dissemination in the local media.
To be included in the study, subjects completed medical examination and were approved in effort electrocardiogram carried out by cardiologist. Participants had not been engaging in regular exercise programs during the previous 12 months and also were classified as physically inactive according to the IPAQ and Baecke Questionnaire. All participants provided their written informed consent prior entering the study.

Exclusion Criteria

The exclusion criteria established for both groups were:
-Presence of acute illness, severe hypertension, diabetes mellitus, myocardial infarction and orthopedic limitations
-Use any medication that could interfere in the test results -Not be approved in effort electrocardiogram carried out by cardiologist.
-The participants must not change the eating habits and physical activity levels, other than the training sessions, for the study period.

Specifically the training subjects should participate in at least 85% of the training sessions and not miss more than two consecutive training sessions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biochemical Metabolic markers related to lipid and glucose homeostasis (composite primary outcome), assesssed by blood sample <br><br>[baseline and at 2, 4 6 months after randomization];Biochemical inflammatory markers (composite primary outcome) which are cytokines and adipokines assessed by blood sample.[baseline and at 2, 4 and 6 months after randomization];body composition markers (composite primary outcome) assessed by skinfold and body circumferences[baseline and at 2, 4 and 6 months after randomization]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath